New hope for ALS patients: experimental drug trial seeks to slow deadly disease
Disease control
ENROLLING_BY_INVITATION
This clinical trial is testing whether an experimental drug called NUZ-001 can slow down ALS progression and help patients maintain physical function longer. The study will involve 160 people with ALS who will receive either the active drug or a placebo. Researchers will measure …
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC